Cortés ROM, Alarcón OS, Matos FFN, Cruz BMR, Pulido GL, Ortiz OAM

Language: Spanish
References: 17
Page: 758-774
PDF size: 315.87 Kb.

ABSTRACT

A quasi-experimental study with less autohemotherapy was performed on patients with vulgar Psoriasis, at the "Celia Sánchez Manduley" hospital from March 2016 - May 2018; with the objective of describing the response of these patients to said treatment. The study population consisted of 71 patients who met the established inclusion / exclusion criteria. The data were obtained from the clinical histories and surveys made to the patients and the results were presented in contingency tables using the Windows Vista system. The variables were studied: clinical response, time of disease evolution, number of sessions, adverse effects, time of appearance of outbreaks. The initial calculation of the PASI was performed and in each evaluation consultation and at the end of the treatment; the percentage of the PASI change was calculated, since the clinical response was made taking into account the categories of the latter. It was concluded that in the study the patients responding to treatment with minor autohemotherapy predominated, without influencing the response time of their disease evolution. The majority of psoriatics needed the most sessions for the improvement or disappearance of the lesions and this therapy was achieved by spacing the outbreaks without adverse effects in any patient.

REFERENCES

1. Manzur Julián, Díaz Almeida J, Cortez Hernández M. Dermatología. La Habana: Editorial Ciencias Médicas; 2002.

2. Fitzpatrick TB. Dermatología en Medicina General. 7ma ed. New York: The McGraw-Hill Companies; 2013.

3. Sánchez-Martínez G. Biblioteca mundial sobre ozonoterapia, una herramienta para la investigación. Revista Española de Ozonoterapia 2014; 4(1): 73-77.

4. Flor García A, Martínez Valvivieso L, Mené F. Actualización en el tratamiento de la Psoriasis. Boletín Farmacoterapéutico de Castilla-La Mancha 2013; 14(1): 1-8.

5. Vargas Mamani JH, Vargas De La Fuente J. Psoriasis vulgar. Rev Cient Cienc Med [Internet]. 2015 [citado 10 Oct 2018]; 18(1): 62-3.

6. Maldonado García CA, Cardona Hernández MA, Jurado Santa Cruz F. Comorbilidades en psoriasis. Rev Cent Dermatol Pascua 2013; 22(1): 15-21.

7. Barreda-Zaleta L, Pérez-Rojas DO, Espinoza-Hernández CJ, Ramírez-Terán AL, Vega-Memije ME. Psoriasis y diabetes mellitus en la consulta dermatológica. Gac Med Mex 2017; 153: 524-5.

8. García-Sánchez L, Montiel-Jarquín ÁJ, Vázquez-Cruz E, May-Salazar A, Gutiérrez-Gabriel I, Loría-Castellanos J. Calidad de vida en el paciente con psoriasis. Gac Med Mex 2017; 153: 185-9.

9. Ballester Torrens M del Mar, Senán Sanz R, Ferran Farres M, Barcala del CF. Terapia tópica de la psoriasis en Atención Primaria. Barcelona: Sociedad Española de Medicina de Familia y Comunitaria; 2011.

10. Vivas S, Núñez Z, González L, Acosta D, Puerta L, Ochoa F. Psoriasis: perfil clínico epidemiológico de la consulta. Servicio de dermatología, ciudad hospitalaria "Dr. Enrique Tejera" 2002-2012. Comunidad y Salud 2014; 12(1): 20-7.

11. Bronsard V, Paul C, Prey S, Puzenat E, Gourraud PA, Aractingi S, et al. What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature. J Eur Acad Dermatol Venereol 2010; 24(Suppl 2): 10-6.

12. Vargas Mamani JH, Vargas De La Fuente J. Psoriasis Vulgar. Rev Cient Cienc Med 2015; 18(1): 62-3.

13. Martínez M, Levrero P, Carusso R, Morales C, Arretche V, Nicola A, et al. Psoriasis Vulgar moderada y severa: opciones terapéuticas (tratamientos convencionales). Arch Med Interna 2013; 35(3): 93-100.

14. Valdés-Solís E, Colorado-García LM, Lozano-Nuevo JJ, Rubio-Guerra AF. Asociación entre la severidad de la psoriasis en placas y el síndrome metabólico. Med Int Méx 2016; 32(2): 190-200.

15. Jurado SF, Torres González S, Ramos Garibay A, Casasola Vargas J, Lizárraga García C, Fernández Arista G. Psoriasis pustulosa. Reporte de un caso. Rev Cent Dermatol Pascua 2005; 14(2): 87-92.

16. Manzur-Barbur MC, Tamayo Escobar S. Psoriasis de Von Zumbusch. Rev Cienc Biomed 2012; 3(2): 327-32.

17. Sánchez Regaña M, Ojeda Cuchillero R, Umbert Millet I, Umbert Millet P, Lupo W, Solé Fernández J. El impacto psicosocial de la psoriasis. Actas Dermosifiliogr 2003; 94(1): 1-64.